--- title: "Mylan Institutional, Inc. Recalls: Agency-Reported Status and History (Oct 1, 2026) | Is It on Recall" description: "Search Mylan Institutional, Inc. recall records, lots, firms and dates. Reported status can be incomplete; use the linked agency notice for current instructions." url: https://isitonrecall.com/brand/mylan-institutional-inc/ updated: 2026-10-01 site: "Is It on Recall" language: en --- [Home](https://isitonrecall.com/) / Brand archive # Mylan Institutional, Inc. recall records **8** reported ongoing 8 records in this archive. Latest source date Mar 7, 2025. FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination. Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/). ## Records and reported status Mar 7, 2025 FDA drug enforcement ### [Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown...](https://isitonrecall.com/recall/fda-drug-d-0290-2025-levothyroxine-sodium-tablets-usp-150-mcg-0-15-mg-rx-only-100-unit-dose-blister-cards-of-10-10-cards/) Super-Potent Drug: Out of specification potency results were obtained. Class II Reported ongoing Distribution: Nationwide in the USA [Official source for Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0290-2025%22) Mar 7, 2025 FDA drug enforcement ### [Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantow...](https://isitonrecall.com/recall/fda-drug-d-0291-2025-levothyroxine-sodium-tablets-usp-125-mcg-0-125-mg-rx-only-100-unit-dose-blister-cards-of-10-10-cards/) Super-Potent Drug: Out of specification potency results were obtained. Class II Reported ongoing Distribution: Nationwide in the USA [Official source for Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0291-2025%22) Nov 19, 2024 FDA drug enforcement ### [Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc...](https://isitonrecall.com/recall/fda-drug-d-0131-2025-levothyroxine-sodium-tablets-usp-100-mcg-0-1-mg-100-tablets-per-carton-10-unit-dose-blister-cards-of/) Subpotent and Superpotent Drug Class II Reported ongoing Distribution: Nationwide in the USA. [Official source for Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 100 Tablets per carton (10 unit dose blister...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0131-2025%22) Nov 19, 2024 FDA drug enforcement ### [Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals I...](https://isitonrecall.com/recall/fda-drug-d-0132-2025-levothyroxine-sodium-tablets-usp-112-mcg-0-112-mg-100-tablets-per-carton-10-unit-dose-blister-cards/) Subpotent and Superpotent Drug Class II Reported ongoing Distribution: Nationwide in the USA. [Official source for Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blist...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0132-2025%22) Nov 19, 2024 FDA drug enforcement ### [Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals I...](https://isitonrecall.com/recall/fda-drug-d-0133-2025-levothyroxine-sodium-tablets-usp-125-mcg-0-125-mg-100-tablets-per-carton-10-unit-dose-blister-cards/) Subpotent and Superpotent Drug Class II Reported ongoing Distribution: Nationwide in the USA. [Official source for Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blist...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0133-2025%22) Nov 19, 2024 FDA drug enforcement ### [Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals I...](https://isitonrecall.com/recall/fda-drug-d-0134-2025-levothyroxine-sodium-tablets-usp-137-mcg-0-137-mg-100-tablets-per-carton-10-unit-dose-blister-cards/) Subpotent and Superpotent Drug Class II Reported ongoing Distribution: Nationwide in the USA. [Official source for Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton (10 unit dose blist...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0134-2025%22) Nov 19, 2024 FDA drug enforcement ### [Levothyroxine Sodium Tablets, USP, 150 mcg (0.150 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals I...](https://isitonrecall.com/recall/fda-drug-d-0135-2025-levothyroxine-sodium-tablets-usp-150-mcg-0-150-mg-100-tablets-per-carton-10-unit-dose-blister-cards/) Subpotent and Superpotent Drug Class II Reported ongoing Distribution: Nationwide in the USA. [Official source for Levothyroxine Sodium Tablets, USP, 150 mcg (0.150 mg), 100 Tablets per carton (10 unit dose blist...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0135-2025%22) Nov 19, 2024 FDA drug enforcement ### [Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals I...](https://isitonrecall.com/recall/fda-drug-d-0136-2025-levothyroxine-sodium-tablets-usp-175-mcg-0-175-mg-100-tablets-per-carton-10-unit-dose-blister-cards/) Subpotent and Superpotent Drug Class II Reported ongoing Distribution: Nationwide in the USA. [Official source for Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blist...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0136-2025%22) ## Reasons in these listed records - Super-Potent Drug: Out of specification potency results were obtained. - Subpotent and Superpotent Drug These examples come from this result page and are not a ranking of every recall reason. ## Checking Mylan Institutional, Inc. ### Is there a recall on mylan institutional, inc. right now? This archive contains 8 records, including 8 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product. ### How do I check my package or product? Compare the product, firm and lot, date, model or serial identifiers with the notice. [Use the label-check guide](https://isitonrecall.com/guides/read-lot-codes/) if you need help locating an identifier. ### Does a matching name mean every item is included? A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall. ### What if the search finds no matching record? This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. [Check source coverage](https://isitonrecall.com/sources/) and the agency's current notices. ### Where can I find older records? Use [monthly archives](https://isitonrecall.com/archives/) or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page. ## Keep checking [Search Mylan Institutional, Inc.](https://isitonrecall.com/check/?q=Mylan%20Institutional%2C%20Inc.) [Browse related products](https://isitonrecall.com/products/) [Review source dates](https://isitonrecall.com/sources/)